NO990793D0 - 7 <alfa> - (<Epsilon> -aminoalkyl) - ° stratrienes, processes for their preparation, pharmaceuticals containing them, and their use in the manufacture of pharmaceuticals - Google Patents

7 <alfa> - (<Epsilon> -aminoalkyl) - ° stratrienes, processes for their preparation, pharmaceuticals containing them, and their use in the manufacture of pharmaceuticals

Info

Publication number
NO990793D0
NO990793D0 NO990793A NO990793A NO990793D0 NO 990793 D0 NO990793 D0 NO 990793D0 NO 990793 A NO990793 A NO 990793A NO 990793 A NO990793 A NO 990793A NO 990793 D0 NO990793 D0 NO 990793D0
Authority
NO
Norway
Prior art keywords
pharmaceuticals
stratrienes
alfa
epsilon
aminoalkyl
Prior art date
Application number
NO990793A
Other languages
Norwegian (no)
Other versions
NO315655B1 (en
NO990793L (en
Inventor
Rolf Bohlmann
Dieter Bittler
Josef Heindi
Nikolaus Heinrich
Helmut Hofmeister
Hermann Kuenzer
Gerhard Sauer
Christa Hegele-Hartung
Rosemarie Lichtner
Yukishige Nishino
Karsten Parczyk
Martin Schneider
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO990793D0 publication Critical patent/NO990793D0/en
Publication of NO990793L publication Critical patent/NO990793L/en
Publication of NO315655B1 publication Critical patent/NO315655B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C07J53/008—3 membered carbocyclic rings in position 15/16
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/006—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton spiro-condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO19990793A 1996-08-20 1999-02-19 7 <alfa> - (<Epsilon> -aminoalkyl) -ostratrienes, pharmaceutical preparations containing them, and their use in the manufacture of pharmaceuticals NO315655B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19635525A DE19635525A1 (en) 1996-08-20 1996-08-20 New 7-alpha-(xi-aminoalkyl)- oestratriene derivatives
PCT/EP1997/004517 WO1998007740A1 (en) 1996-08-20 1997-08-20 7α-(κ-AMINOALKYL)ESTRATRIENES, PROCESS FOR PREPARING THE SAME, PHARMACEUTICAL PREPARATIONS CONTAINING SAID 7α-(κ-AMINOALKYL)ESTRATRIENES AND THEIR USE FOR PREPARING MEDICAMENTS

Publications (3)

Publication Number Publication Date
NO990793D0 true NO990793D0 (en) 1999-02-19
NO990793L NO990793L (en) 1999-04-20
NO315655B1 NO315655B1 (en) 2003-10-06

Family

ID=7804367

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19990793A NO315655B1 (en) 1996-08-20 1999-02-19 7 <alfa> - (<Epsilon> -aminoalkyl) -ostratrienes, pharmaceutical preparations containing them, and their use in the manufacture of pharmaceuticals

Country Status (29)

Country Link
EP (1) EP0920441B1 (en)
JP (1) JP2001503024A (en)
KR (1) KR20000068261A (en)
CN (1) CN1231670A (en)
AR (1) AR009278A1 (en)
AT (1) ATE231882T1 (en)
AU (1) AU728843B2 (en)
BG (1) BG62972B1 (en)
BR (1) BR9711328A (en)
CA (1) CA2263708A1 (en)
CZ (1) CZ57999A3 (en)
DE (2) DE19635525A1 (en)
DK (1) DK0920441T3 (en)
EA (1) EA001577B1 (en)
EE (1) EE04021B1 (en)
ES (1) ES2191857T3 (en)
HU (1) HUP9903106A3 (en)
IL (1) IL128601A (en)
IS (1) IS4976A (en)
NO (1) NO315655B1 (en)
NZ (1) NZ334277A (en)
PL (1) PL186309B1 (en)
PT (1) PT920441E (en)
SK (1) SK18899A3 (en)
TR (1) TR199900432T2 (en)
TW (1) TW552267B (en)
UA (1) UA50792C2 (en)
WO (1) WO1998007740A1 (en)
ZA (1) ZA977482B (en)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20000129A1 (en) * 1997-12-23 2000-03-11 Schering Ag 11 BETA-HALOGEN-STRATRIENS SUBSTITUTED IN 7 ALPHA, AS WELL AS THE PROCEDURE TO PREPARE PHARMACEUTICAL PREPARATIONS CONTAINING SUCH 11 BETA-HALOGEN-STRATRENS SUBSTITUTED IN 7 ALPHA
US6054446A (en) * 1997-12-24 2000-04-25 Sri International Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
US6548491B2 (en) 1997-12-24 2003-04-15 Sri International Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
US6503896B1 (en) 1997-12-24 2003-01-07 Sri International Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
DE19807791A1 (en) 1998-02-19 1999-08-26 Schering Ag Combination preparation of estrogen with 7-aminoalkyl-estratriene antiestrogen, useful in hormone replacement therapy, e.g. for treatment osteoporosis, Alzheimer's disease and hot flushes
DE19833786A1 (en) * 1998-07-18 2000-01-20 Schering Ag New diphenyl-benzocycloheptene derivatives, are tissue-selective estrogens and antiestrogens useful e.g. for treating osteoporosis or hormone-dependent tumors or in hormone replacement therapy
DE19842123C1 (en) * 1998-09-05 2000-07-13 Schering Ag 11beta-fluoro-7alpha- (14,14,15,15,15-pentafluoro-6-methyl-10-thia-6-azapentadecyl) estra-1,3,5 (10) - triene-3,17beta-diol as crystalline solvate
DE19906159A1 (en) * 1999-02-09 2000-08-10 Schering Ag 16-hydroxyestratrienes as selectively active estrogens
EP1204657A1 (en) * 1999-08-18 2002-05-15 Schering Aktiengesellschaft Piperidine and pyrrolidine derivatives displaying neuronal activity
GB0000313D0 (en) * 2000-01-10 2000-03-01 Astrazeneca Uk Ltd Formulation
DE10019171A1 (en) * 2000-04-07 2001-10-18 Schering Ag Compositions for use as penetration enhancers in transdermal formulations for highly lipophilic active ingredients
DE10159217A1 (en) * 2001-11-27 2003-06-05 Schering Ag 17alpha-alkyl-17ß-oxy-estratrienes and intermediates for their preparation, use of 17alpha-alkyl-17ß-oxy-estratriene for the preparation of medicaments and pharmaceutical preparations
AU2006202187B2 (en) * 2001-11-27 2008-11-06 Bayer Schering Pharma Aktiengesellschaft 17alpah-alkyl-17beta-oxy-estratrienes and intermediate products for their production, uses thereof and pharmaceutical preparations
US20040242551A1 (en) * 2003-05-28 2004-12-02 Schering Ag Composition comprising antiprogestins and pure antiestrogens for prophylaxis and treatment of hormone-dependent diseases
ATE482966T1 (en) 2004-07-27 2010-10-15 Sicor Inc METHOD FOR PRODUCING 7-ALPHA-ALKYLATED 19-NORSTEROIDS
KR20080069268A (en) 2005-11-22 2008-07-25 스미또모 가가꾸 가부시끼가이샤 Organic sulfur compounds and use thereof as arthropodicides
DE102007049630A1 (en) 2007-10-11 2009-10-29 Bayer Schering Pharma Aktiengesellschaft New amide compounds used for therapy and/or prophylaxis of gynecological diseases e.g. endometriosis, for female fertility control and female hormone replacement therapy
DE102007023614A1 (en) 2007-05-21 2008-11-27 Bayer Schering Pharma Aktiengesellschaft New amide compounds used for treatment of gynecological diseases e.g. endometriosis, for female fertility control and female hormone replacement therapy, has general formula
JP5298631B2 (en) 2007-05-18 2013-09-25 住友化学株式会社 Organic sulfur compounds and their use for controlling harmful arthropods
JP2009001551A (en) 2007-05-18 2009-01-08 Sumitomo Chemical Co Ltd Organic sulfur compound and its use for controlling harmful arthropod
TW200904329A (en) 2007-05-18 2009-02-01 Sumitomo Chemical Co Organic sulfur compound and its use for controlling harmful arthropod
DE102007032800A1 (en) 2007-07-10 2009-01-15 Bayer Schering Pharma Aktiengesellschaft Nonsteroidal progesterone receptor modulators
EA017385B1 (en) 2007-10-16 2012-12-28 Репрос Терапьютикс Инк. Use of trans-clomiphene for reducing fasting glucose level
DE102007058747A1 (en) 2007-12-05 2009-06-10 Bayer Schering Pharma Aktiengesellschaft Nonsteroidal progesterone receptor modulators
EP2070941A1 (en) 2007-12-14 2009-06-17 Bayer Schering Pharma Aktiengesellschaft Stereoselective synthesis of selective estrogen receptor down-regulators
EP2070909A1 (en) 2007-12-15 2009-06-17 Bayer Schering Pharma AG Non-steroidal progesterone receptor modulators
DE102008057230A1 (en) 2008-11-11 2010-05-12 Bayer Schering Pharma Aktiengesellschaft Synergistic pharmaceutical combination with an estrogen receptor antagonist and a progestin
JP5212350B2 (en) * 2008-12-24 2013-06-19 住友化学株式会社 Halogen-containing organic sulfur compounds and uses thereof
EP2258375A1 (en) 2009-06-04 2010-12-08 Bayer Schering Pharma Aktiengesellschaft 17B-alkyl-17alpha-oxy-estratrienes
DE102009034362A1 (en) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluoroethyl-estra-4,9 (10) -diene-11-aryl derivatives, process for their preparation and their use for the treatment of diseases
DE102009034367A1 (en) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluoroethyl-estra-4,9 (10) -diene-11-benzylidene derivatives, process for their preparation and their use for the treatment of diseases
DE102009034366A1 (en) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluoroethyl-estra-4,9 (10) -diene-11-methyleneoxyalkylene aryl derivatives, process for their preparation and their use for the treatment of diseases
DE102009034368A1 (en) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluoroethyl-estra-4,9 (10) -diene-11-acyloxyalkylenephenyl derivatives, process for their preparation and their use for the treatment of diseases
DE102009034526A1 (en) 2009-07-21 2011-02-10 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluoroethyl-estra-4,9 (10) -diene-11-ethynylphenyl derivatives, process for their preparation and their use for the treatment of diseases
DE102009034525A1 (en) 2009-07-21 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluoroethyl-estra-4,9 (10) -diene-11-aryl derivatives, process for their preparation and their use for the treatment of diseases
WO2011092127A1 (en) 2010-01-26 2011-08-04 Bayer Schering Pharma Aktiengesellschaft 14,17-bridged estratriene derivatives comprising heterocyclic bioisosteres for the phenolic a-ring
DE102010007722A1 (en) 2010-02-10 2011-08-11 Bayer Schering Pharma Aktiengesellschaft, 13353 Progesterone receptor antagonist
DE102010007719A1 (en) 2010-02-10 2011-08-11 Bayer Schering Pharma Aktiengesellschaft, 13353 Progesterone receptor antagonist
CN107693794A (en) 2010-06-16 2018-02-16 恩多研究公司 The method for treating or preventing estrogen relative diseases
DE102010030538A1 (en) 2010-06-25 2011-12-29 Bayer Schering Pharma Aktiengesellschaft 6,7-Dihydro-5H-benzo [7] annulene derivatives, process for their preparation, pharmaceutical preparations containing them and their use for the preparation of medicaments
DE102011004899A1 (en) 2011-03-01 2012-09-06 Bayer Pharma Aktiengesellschaft New 17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl-derivatives are progesterone receptor antagonists useful to treat and prevent e.g. uterine fibroids, endometriosis, heavy menstrual bleeding and meningioma
DE102011087987A1 (en) 2011-12-08 2013-06-13 Bayer Intellectual Property Gmbh 6,7-Dihydro-5H-benzo [7] annulene derivatives, process for their preparation, pharmaceutical preparations containing them and their use for the preparation of medicaments
JP2015508825A (en) 2012-02-29 2015-03-23 レプロス セラピューティクス インコーポレイティド Combination therapy to treat androgen deficiency
PL3461834T3 (en) 2013-03-13 2021-12-27 Sage Therapeutics, Inc. Neuroactive steroids
BR112015025706A2 (en) 2013-04-11 2017-07-18 Bayer Pharma AG progesterone receptor antagonist dosage form
EP2987799B1 (en) * 2013-04-18 2020-04-08 Xi'an Libang Pharmaceutical Technology Co.,ltd. Ester derivative of 7-alpha-[9-(4,4,5,5,5-pentafluoropentylsulphinyl)nonyl]oestra-1,3,5(10)-triene-3,17beta-diol having antitumour activity and preparation method thereof
AU2016352592B2 (en) 2015-11-10 2023-04-27 Paracrine Therapeutics Ab Treatment of ER-negative breast cancer with an PDGF-CC inhibitor and an anti estrogen
SI3436022T1 (en) 2016-04-01 2022-08-31 Sage Therapeutics, Inc. Oxysterols and methods of use thereof
WO2017193046A1 (en) 2016-05-06 2017-11-09 Sage Therapeutics, Inc. Oxysterols and methods of use thereof
MA45598B1 (en) 2016-07-07 2021-09-30 Sage Therapeutics Inc 24-hydroxy steroles substituted in position 11 for the treatment of diseases linked to the nmda receptor
MX2019003724A (en) 2016-09-30 2019-09-04 Sage Therapeutics Inc C7 substituted oxysterols and methods as nmda modulators.
IL293231A (en) 2016-10-18 2022-07-01 Sage Therapeutics Inc Oxysterols and methods of use thereof
CN115505019B (en) * 2022-11-07 2024-01-26 南宁师范大学 7-amide substituted estrogenic compounds, and preparation method and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8327256D0 (en) * 1983-10-12 1983-11-16 Ici Plc Steroid derivatives
HU208150B (en) * 1988-10-31 1993-08-30 Endorecherche Inc Process for producing new estrogen derivatives having steroid hormone inhibitor activity and pharmaceutical compositions comprising such derivatives
DE3925507A1 (en) * 1989-07-28 1991-01-31 Schering Ag 14,17 (ALPHA) ETHENO AND ETHANOESTRATRIA, METHOD FOR PRODUCING THESE COMPOUNDS, AND THEIR USE FOR PRODUCING MEDICINAL PRODUCTS
DE4218743C2 (en) * 1992-06-04 2001-10-25 Schering Ag Process for the preparation of C (7) -substituted Estra-1,3,5 (10) -trienes and new starting products for this process

Also Published As

Publication number Publication date
EA199900210A1 (en) 1999-08-26
CZ57999A3 (en) 1999-08-11
TR199900432T2 (en) 1999-04-21
PT920441E (en) 2003-06-30
KR20000068261A (en) 2000-11-25
ZA977482B (en) 1998-02-23
EP0920441A1 (en) 1999-06-09
NZ334277A (en) 2000-10-27
EE9900075A (en) 1999-10-15
NO315655B1 (en) 2003-10-06
NO990793L (en) 1999-04-20
ES2191857T3 (en) 2003-09-16
DE59709239D1 (en) 2003-03-06
IL128601A0 (en) 2000-01-31
UA50792C2 (en) 2002-11-15
AU728843B2 (en) 2001-01-18
JP2001503024A (en) 2001-03-06
IS4976A (en) 1999-02-11
AR009278A1 (en) 2000-04-12
ATE231882T1 (en) 2003-02-15
EE04021B1 (en) 2003-04-15
CA2263708A1 (en) 1998-02-26
PL331863A1 (en) 1999-08-16
DK0920441T3 (en) 2003-05-26
TW552267B (en) 2003-09-11
WO1998007740A1 (en) 1998-02-26
BG62972B1 (en) 2000-12-29
HUP9903106A3 (en) 2000-05-29
PL186309B1 (en) 2003-12-31
HUP9903106A2 (en) 2000-03-28
SK18899A3 (en) 1999-08-06
DE19635525A1 (en) 1998-02-26
EA001577B1 (en) 2001-06-25
EP0920441B1 (en) 2003-01-29
IL128601A (en) 2003-07-31
BG103185A (en) 1999-11-30
BR9711328A (en) 1999-08-17
AU4552097A (en) 1998-03-06
CN1231670A (en) 1999-10-13

Similar Documents

Publication Publication Date Title
NO990793L (en) 7 &lt;alfa&gt; - (&lt;Epsilon&gt; -aminoalkyl) - ° stratrienes, processes for their preparation, pharmaceuticals containing them, and their use in the manufacture of pharmaceuticals
NO304488B1 (en) 5-membered heteroaryloxazolidinones, their use in the manufacture of drugs and drugs containing the compound
NO984852L (en) New benzazepine derivatives, drugs containing the compounds and their use in the manufacture of the drugs
HUP0102187A3 (en) Azolo triazines and pyrimidines, pharmaceutical compositions containing them and use of the compounds
NO20021714D0 (en) 2-Phenyl-substituted imidazotriazinones, process for their preparation and use of the compounds
AP9400654A0 (en) Novel imidazole compounds, processes for the preparation thereof and their use in therapay
NO20010013L (en) Sulfur-substituted sulfonylaminocarboxylic acid N-arylamides, their preparation and use as well as pharmaceutical preparations containing the compounds
EE9700044A (en) Heteroaryloxazolidinones, process for their preparation, use in the manufacture of medicaments and medicaments containing these compounds.
NO20010277L (en) Benzocycloheptenes, processes for their preparation, pharmaceutical preparations containing them, and their use in the manufacture of medicaments
NO304603B1 (en) Water dispersible particulate polymer blend, process for preparing the blend and use of the blend
NO169446C (en) PROCEDURE FOR THE PREPARATION OF RIG POLYURETAN FOAM, AND THE PROCEDURAL MATERIAL FOR USE IN THE PROCEDURE
ID23421A (en) 3-SUBSTITUTED 3,4-DIHYDROTIENO [2,3-D] PYRIMIDIN, MANUFACTURE AND USE OF IT
NO308287B1 (en) Substituted 4-phenyl-6-amino-nicotinic acid derivatives, drugs containing them and their use
ZA941993B (en) Amidine derivatives containing heterocyclic groups the preparation and use thereof
ID17076A (en) 2,4-DISUBSTITUTION OF PYRIMIDINE, THE PROCESS FOR MAKING THE SAME SUBSTANCE AND PHARMACY COMPOSITION CONTAINING THE SAME SUBSTANCE
ZA952410B (en) Substituted heterocyclic carboxamioesters their preparation and their use as pharmaceuticals
NO306060B1 (en) Substituted cinnamic acid guanides, their use, and drugs containing the guanides
NO960529D0 (en) Substituted benzenesulfonylureas and thioureas, processes for their preparation and their use in the preparation of pharmaceutical compositions and pharmaceutical compositions containing the compounds
ID24222A (en) 3-SUBSTITUTED 3, 3,5,5,7-TETRAHIDROPIROLO [3 &#39;, 4&#39;: 4,5] TIENO- [2,3-d] PYRIMIDINS, MANUFACTURE AND USE
HUP0105111A3 (en) 2,5-substituted benzolsulfonylureas and thioureas, methods for the production thereof, use thereof and pharmaceutical preparations containing the same
ID23156A (en) AMIDINA&#39;S DEMONSTRATIONS, THE PROCESS OF MAKING COMPOSITION AND ITS USE
NO955146D0 (en) Process for the preparation of polymeric materials with high chemical and mechanical resistance, as well as polymeric materials with high chemical and mechanical resistance
NO308528B1 (en) Substituted 1-naphthoylguanidines, their use in the manufacture of medicaments and curing agents containing the compounds
NO965370D0 (en) Substituted chromanylsulfonyl (thio) ureas, processes for their preparation, their use in pharmaceutical compositions and pharmaceutical compositions containing the compounds
HUP9904110A2 (en) Ptx sensitive g proteins, the production and use thereof

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees